Vuno Inc. news
VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung’s Premium Ceiling Type Digital Radiography System
October 6, 2021 – South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO’s ar
South Korean artificial intelligence (AI) developer, VUNO Inc. announced today that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest prediction through vital signs.
VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that an
VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung’s Premium Mobile X-ray System
VUNO’s road-tested, clinically-proven chest X-ray detection software is reshaping the delivery of medical imaging diagnostics by being fully integrated with Samsung Electronics’ X-ray system
June 25, 2021 - South Korean artificial intelligence (AI) developer, VUNO Inc., announced today a partnership with Samsung Electronics Co., Ltd., global m
South Korean artificial intelligence (AI) developer, VUNO inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company’s artificial intelligence-based electrocardiogram (ECG) analysis software VUNO Med®-DeepECG™ as the ministry’s 16th Breakthrough Device. Using deep learning, the software analyzes ECG data to zero in on heart failure, myocardial infarction and arrhythmia. <